(Q46428095)

22 December 2017

title

Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma (English)

1 reference

22 December 2017

author

Orlando Guntinas-Lichius

9

object named as

Orlando Guntinas-Lichius

1 reference

22 December 2017

7

Inga Wedemeyer

1 reference

22 December 2017

Uta Drebber

6

object named as

Uta Drebber

1 reference

22 December 2017

author name string

Simon Florian Preuss

1

1 reference

22 December 2017

Antje Weinell

2

1 reference

22 December 2017

Markus Molitor

3

1 reference

22 December 2017

Robert Semrau

4

1 reference

22 December 2017

Markus Stenner

5

1 reference

22 December 2017

Thomas K Hoffmann

8

1 reference

22 December 2017

Jens Peter Klussmann

10

1 reference

22 December 2017

publication date

1 October 2008

1 reference

22 December 2017

published in

Head & Neck

1 reference

22 December 2017

volume

30

1 reference

22 December 2017

issue

10

1 reference

22 December 2017

page(s)

1318-1324

1 reference

22 December 2017

Cancer gene therapy using a survivin mutant adenovirus

cites work

1 reference

Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.

21 January 2018

1 reference

Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas

21 January 2018

1 reference

7 January 2021

Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer

1 reference

7 January 2021

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck.

1 reference

7 January 2021

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

7 January 2021

Survivin study: an update of "what is the next wave"?

1 reference

7 January 2021

Survivin study: what is the next wave?

1 reference

7 January 2021

Survivin, versatile modulation of cell division and apoptosis in cancer

1 reference

7 January 2021

Survivin as prognostic factor in squamous cell carcinoma of the oral cavity

1 reference

7 January 2021

Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma

1 reference

7 January 2021

Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.

1 reference

7 January 2021

Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome

1 reference

7 January 2021

Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters.

1 reference

7 January 2021

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

1 reference

7 January 2021

Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway

1 reference

7 January 2021

Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin

1 reference

7 January 2021

Aberrant regulation of survivin by the RB/E2F family of proteins

1 reference

7 January 2021

DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes

1 reference

7 January 2021

Survivin and molecular pathogenesis of colorectal cancer.

1 reference

7 January 2021

Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras

1 reference

7 January 2021

Analysis of Survivin Expression in a Spectrum of Benign to Malignant Lesions of the Breast

1 reference

7 January 2021

Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells

1 reference

7 January 2021

Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer

1 reference

7 January 2021

Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience

1 reference

7 January 2021

Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer

1 reference

7 January 2021

Survivin expression in oral squamous cell carcinoma.

1 reference

7 January 2021

Molecular biology in head and neck cancer

1 reference

7 January 2021

EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathway

1 reference

7 January 2021

High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis

1 reference

7 January 2021

Nuclear survivin as a biomarker for non-small-cell lung cancer

1 reference

7 January 2021

Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer

1 reference

7 January 2021

Nuclear or cytoplasmic expression of survivin: what is the significance?

1 reference

7 January 2021

Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker

1 reference

7 January 2021

Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.20876

1 reference

22 December 2017

1 reference

22 December 2017